Oxyphenbutazone

DB03585

small molecule approved withdrawn

Deskripsi

Oxyphenbutazone was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression.

Struktur Molekul 2D

Berat 324.3737
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) -
Volume Distribusi -
Klirens (Clearance) -

Absorpsi

Data absorpsi tidak tersedia.

Metabolisme

Data metabolisme tidak tersedia.

Rute Eliminasi

Data eliminasi belum tersedia.

Interaksi Makanan

1 Data
  • 1. Take with food. Food reduces irritation.

Interaksi Obat

1400 Data
Amlodipine Oxyphenbutazone may decrease the antihypertensive activities of Amlodipine.
Phentermine The risk or severity of hypertension can be increased when Phentermine is combined with Oxyphenbutazone.
Midodrine The risk or severity of hypertension can be increased when Midodrine is combined with Oxyphenbutazone.
Eletriptan The risk or severity of hypertension can be increased when Eletriptan is combined with Oxyphenbutazone.
Isoetharine The risk or severity of hypertension can be increased when Isoetharine is combined with Oxyphenbutazone.
Ziprasidone The risk or severity of hypertension can be increased when Ziprasidone is combined with Oxyphenbutazone.
Methysergide The risk or severity of hypertension can be increased when Methysergide is combined with Oxyphenbutazone.
Cabergoline The risk or severity of hypertension can be increased when Cabergoline is combined with Oxyphenbutazone.
Zolmitriptan The risk or severity of hypertension can be increased when Zolmitriptan is combined with Oxyphenbutazone.
Dihydroergotamine The risk or severity of hypertension can be increased when Dihydroergotamine is combined with Oxyphenbutazone.
Methylergometrine The risk or severity of hypertension can be increased when Methylergometrine is combined with Oxyphenbutazone.
Norepinephrine The risk or severity of hypertension can be increased when Norepinephrine is combined with Oxyphenbutazone.
Mirtazapine The risk or severity of hypertension can be increased when Mirtazapine is combined with Oxyphenbutazone.
Phenylephrine The risk or severity of hypertension can be increased when Phenylephrine is combined with Oxyphenbutazone.
Phenylpropanolamine The risk or severity of hypertension can be increased when Phenylpropanolamine is combined with Oxyphenbutazone.
Promazine The risk or severity of hypertension can be increased when Promazine is combined with Oxyphenbutazone.
Droperidol The risk or severity of hypertension can be increased when Droperidol is combined with Oxyphenbutazone.
Doxapram The risk or severity of hypertension can be increased when Doxapram is combined with Oxyphenbutazone.
Atropine The risk or severity of hypertension can be increased when Atropine is combined with Oxyphenbutazone.
Lisuride The risk or severity of hypertension can be increased when Lisuride is combined with Oxyphenbutazone.
Linezolid The risk or severity of hypertension can be increased when Linezolid is combined with Oxyphenbutazone.
Metaraminol The risk or severity of hypertension can be increased when Metaraminol is combined with Oxyphenbutazone.
Furazolidone The risk or severity of hypertension can be increased when Furazolidone is combined with Oxyphenbutazone.
Epinephrine The risk or severity of hypertension can be increased when Epinephrine is combined with Oxyphenbutazone.
Thioridazine The risk or severity of hypertension can be increased when Thioridazine is combined with Oxyphenbutazone.
Ergotamine The risk or severity of hypertension can be increased when Ergotamine is combined with Oxyphenbutazone.
Nicergoline The risk or severity of hypertension can be increased when Nicergoline is combined with Oxyphenbutazone.
Sufentanil The risk or severity of hypertension can be increased when Sufentanil is combined with Oxyphenbutazone.
Methoxamine The risk or severity of hypertension can be increased when Methoxamine is combined with Oxyphenbutazone.
Risperidone The risk or severity of hypertension can be increased when Risperidone is combined with Oxyphenbutazone.
Tranylcypromine The risk or severity of hypertension can be increased when Tranylcypromine is combined with Oxyphenbutazone.
Isoflurane The risk or severity of hypertension can be increased when Isoflurane is combined with Oxyphenbutazone.
Propiomazine The risk or severity of hypertension can be increased when Propiomazine is combined with Oxyphenbutazone.
Alfentanil The risk or severity of hypertension can be increased when Alfentanil is combined with Oxyphenbutazone.
Minaprine The risk or severity of hypertension can be increased when Minaprine is combined with Oxyphenbutazone.
Orciprenaline The risk or severity of hypertension can be increased when Orciprenaline is combined with Oxyphenbutazone.
Propofol The risk or severity of hypertension can be increased when Propofol is combined with Oxyphenbutazone.
Phenmetrazine The risk or severity of hypertension can be increased when Phenmetrazine is combined with Oxyphenbutazone.
Trifluoperazine The risk or severity of hypertension can be increased when Trifluoperazine is combined with Oxyphenbutazone.
Pseudoephedrine The risk or severity of hypertension can be increased when Pseudoephedrine is combined with Oxyphenbutazone.
Benzphetamine The risk or severity of hypertension can be increased when Benzphetamine is combined with Oxyphenbutazone.
Ritodrine The risk or severity of hypertension can be increased when Ritodrine is combined with Oxyphenbutazone.
Flupentixol The risk or severity of hypertension can be increased when Flupentixol is combined with Oxyphenbutazone.
Remifentanil The risk or severity of hypertension can be increased when Remifentanil is combined with Oxyphenbutazone.
Bitolterol The risk or severity of hypertension can be increased when Bitolterol is combined with Oxyphenbutazone.
Oxymetazoline The risk or severity of hypertension can be increased when Oxymetazoline is combined with Oxyphenbutazone.
Diethylpropion The risk or severity of hypertension can be increased when Diethylpropion is combined with Oxyphenbutazone.
Salmeterol The risk or severity of hypertension can be increased when Salmeterol is combined with Oxyphenbutazone.
Naratriptan The risk or severity of hypertension can be increased when Naratriptan is combined with Oxyphenbutazone.
Formoterol The risk or severity of hypertension can be increased when Formoterol is combined with Oxyphenbutazone.
Frovatriptan The risk or severity of hypertension can be increased when Frovatriptan is combined with Oxyphenbutazone.
Methoxyflurane The risk or severity of hypertension can be increased when Methoxyflurane is combined with Oxyphenbutazone.
Selegiline The risk or severity of hypertension can be increased when Selegiline is combined with Oxyphenbutazone.
Ergoloid mesylate The risk or severity of hypertension can be increased when Ergoloid mesylate is combined with Oxyphenbutazone.
Isoprenaline The risk or severity of hypertension can be increased when Isoprenaline is combined with Oxyphenbutazone.
Arbutamine The risk or severity of hypertension can be increased when Arbutamine is combined with Oxyphenbutazone.
Dutasteride The risk or severity of hypertension can be increased when Dutasteride is combined with Oxyphenbutazone.
Halothane The risk or severity of hypertension can be increased when Halothane is combined with Oxyphenbutazone.
Moclobemide The risk or severity of hypertension can be increased when Moclobemide is combined with Oxyphenbutazone.
Pergolide The risk or severity of hypertension can be increased when Pergolide is combined with Oxyphenbutazone.
Desflurane The risk or severity of hypertension can be increased when Desflurane is combined with Oxyphenbutazone.
Bromocriptine The risk or severity of hypertension can be increased when Bromocriptine is combined with Oxyphenbutazone.
Finasteride The risk or severity of hypertension can be increased when Finasteride is combined with Oxyphenbutazone.
Aripiprazole The risk or severity of hypertension can be increased when Aripiprazole is combined with Oxyphenbutazone.
Isocarboxazid The risk or severity of hypertension can be increased when Isocarboxazid is combined with Oxyphenbutazone.
Ergometrine The risk or severity of hypertension can be increased when Ergometrine is combined with Oxyphenbutazone.
Lisdexamfetamine The risk or severity of hypertension can be increased when Lisdexamfetamine is combined with Oxyphenbutazone.
Fenoterol The risk or severity of hypertension can be increased when Fenoterol is combined with Oxyphenbutazone.
Pirbuterol The risk or severity of hypertension can be increased when Pirbuterol is combined with Oxyphenbutazone.
Ephedra sinica root The risk or severity of hypertension can be increased when Ephedra sinica root is combined with Oxyphenbutazone.
Ephedrine The risk or severity of hypertension can be increased when Ephedrine is combined with Oxyphenbutazone.
Mephentermine The risk or severity of hypertension can be increased when Mephentermine is combined with Oxyphenbutazone.
Procaterol The risk or severity of hypertension can be increased when Procaterol is combined with Oxyphenbutazone.
Yohimbine The risk or severity of hypertension can be increased when Yohimbine is combined with Oxyphenbutazone.
Methotrimeprazine The risk or severity of hypertension can be increased when Methotrimeprazine is combined with Oxyphenbutazone.
Clenbuterol The risk or severity of hypertension can be increased when Clenbuterol is combined with Oxyphenbutazone.
Bambuterol The risk or severity of hypertension can be increased when Bambuterol is combined with Oxyphenbutazone.
MMDA The risk or severity of hypertension can be increased when MMDA is combined with Oxyphenbutazone.
Midomafetamine The risk or severity of hypertension can be increased when Midomafetamine is combined with Oxyphenbutazone.
2,5-Dimethoxy-4-ethylamphetamine The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Oxyphenbutazone.
4-Methoxyamphetamine The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Oxyphenbutazone.
4-Bromo-2,5-dimethoxyamphetamine The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Oxyphenbutazone.
Tenamfetamine The risk or severity of hypertension can be increased when Tenamfetamine is combined with Oxyphenbutazone.
Chlorphentermine The risk or severity of hypertension can be increased when Chlorphentermine is combined with Oxyphenbutazone.
Dextroamphetamine The risk or severity of hypertension can be increased when Dextroamphetamine is combined with Oxyphenbutazone.
Phendimetrazine The risk or severity of hypertension can be increased when Phendimetrazine is combined with Oxyphenbutazone.
Solifenacin The risk or severity of hypertension can be increased when Solifenacin is combined with Oxyphenbutazone.
Periciazine The risk or severity of hypertension can be increased when Periciazine is combined with Oxyphenbutazone.
Acepromazine The risk or severity of hypertension can be increased when Acepromazine is combined with Oxyphenbutazone.
Thioproperazine The risk or severity of hypertension can be increased when Thioproperazine is combined with Oxyphenbutazone.
Zuclopenthixol The risk or severity of hypertension can be increased when Zuclopenthixol is combined with Oxyphenbutazone.
Epicaptopril The risk or severity of hypertension can be increased when Epicaptopril is combined with Oxyphenbutazone.
Clorgiline The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Clorgiline.
1-benzylimidazole The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with 1-benzylimidazole.
Iproniazid The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Iproniazid.
Nialamide The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Nialamide.
Lysergic acid diethylamide The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Lysergic acid diethylamide.
Dronedarone The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Dronedarone.
Flibanserin The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Flibanserin.
Iloperidone The risk or severity of hypertension can be increased when Oxyphenbutazone is combined with Iloperidone.

Target Protein

Albumin ALB
Group IIE secretory phospholipase A2 PLA2G2E

Referensi & Sumber

Belum ada data referensi/link/attachment untuk obat ini pada database. Jalankan import DrugBank untuk mengisi field referensi.

Contoh Produk & Brand

Produk: 2 • International brands: 2
Produk
  • Oxybutazone Tab 100mg
    Tablet • 100 mg • Oral • Canada • Approved
  • Oxyphenbutazone 100mg Tablets
    Tablet • 100 mg / tab • Oral • Canada • Approved
International Brands
  • Oxyphenbutazone
  • Reozon

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul